🔎 Trials Near Me

Početna › Rak prostate › Delaware › Newark

Kliničke studije za Rak prostate u gradu Newark, DE

10 studija za Rak prostate traži sudionike na lokacijama u gradu Newark i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

U tijeku regrutacijaFaza 1/2
  • Medical Oncology Hematology Consultants, Newark
Od 12 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT04585750

Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

U tijeku regrutacijaFaza 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
Od 18 godina i više · Muškarci · Ažurirano 2. lis 2026. · NCT07200830

Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

U tijeku regrutacijaFaza 2
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06632977

A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

U tijeku regrutacijaFaza 3
  • Medical Oncology Hematology Consultants Helen F Graham Cancer Center, Newark
Od 18 godina i više · Muškarci · Ažurirano 22. ruj 2026. · NCT07213674

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

U tijeku regrutacijaFaza 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
Od 18 godina i više · Muškarci · Ažurirano 10. ruj 2026. · NCT05946213

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

U tijeku regrutacijaFaza 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
  • Christiana Care Health System-Christiana Hospital, Newark
  • i još 1
Od 18 godina i više · Muškarci · Ažurirano 14. srp 2026. · NCT06592924

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

U tijeku regrutacijaFaza 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
  • Christiana Care Health System-Christiana Hospital, Newark
  • i još 1
Od 18 godina i više · Muškarci · Ažurirano 22. sij 2026. · NCT06470243

Vitamin D for Prostate Endocrine Therapy

U tijeku regrutacijaFaza 3
  • Helen F Graham Cancer Center, Newark
  • Medical Oncology Hematology Consultants PA, Newark
Od 50 godina i više · Muškarci · Ažurirano 15. sij 2026. · NCT05838716

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

U tijeku regrutacijaOpažajna studija
  • Massive Bio SYNERGY-AI site, Newark
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

U tijeku regrutacijaFaza 3
  • Helen F Graham Cancer Center, Newark
  • Christiana Care Health System-Christiana Hospital, Newark
Od 18 godina i više · Muškarci · Ažurirano 11. ruj 2025. · NCT03678025

Studije za Rak prostate u drugim gradovima

Ostale studije u gradu Newark

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.